Advertisement
For patients with type 1 diabetes

Digital Assistant in Closed-Loop Control Mode Beneficial in T1DM

0
Overnight-only and 24/7 closed-loop control reduce hypoglycemia, increase time in range
A case of postoperative acute gouty arthritis following laparoscopic cholecystectomy with umbilical hernioplasty

Post-Op Gouty Arthritis Described in Patient Taking Thiazide

0
Case of postoperative acute gouty arthritis documented, secondary to hydrochlorothiazide use
More than one-third of advanced melanoma patients were still alive five years after starting therapy with nivolumab (Opdivo)

AACR: Nivolumab Appears to Up Survival in Advanced Melanoma

0
One-third of study participants lived five years or more after starting treatment
Network meta-analysis

Network Meta-Analysis Recommends Prostaglandins for Glaucoma

0
Highest-ranking class for reducing intraocular pressure was prostaglandins for 1999, 2004, 2009
For patients with post-myocardial infarction heart failure

Mineralocorticoid Receptor Antagonists No Benefit Post MI

0
MRA in addition to standard therapy does not improve outcome in setting of post-MI heart failure
For renal transplant recipients

Oral Nicotinamide Safe for Renal Transplant Recipients

0
Treatment linked to nonsignificant reductions in new non-melanoma skin cancers
For perimenopausal and postmenopausal women

Review: Paroxetine Reduces Vasomotor Symptoms

0
Moderate quality evidence shows reduction in frequency of hot flashes with paroxetine
Metformin is associated with reduced cardiovascular mortality compared with sulfonylureas

Lower CVD Mortality for Metformin Versus Sulfonylureas

0
Large analysis found up to 40 percent lower risk of heart disease mortality versus sulfonylureas
A new two-step Ebola vaccine strategy has shown some promise in early clinical trials

Early Trials Offer Promising Results for 2-Step Ebola Vaccine

0
One vaccine provided first as a primer, and the second given as a booster
Pembrolizumab (Keytruda)

AACR: Pembrolizumab Effective Against Merkel-Cell Carcinoma

0
Intravenous medication blocks programmed death 1 (PD-1) immune inhibitory pathway